Vermillion & White Wealth Management Group’s Cidara Therapeutics CDTX Stock Holding History

Vermillion & White Wealth Management Group’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45	Closed	-$9.94K	–	141
2025 Q4	$9.94K	Hold	45	–	–	0.01%	317
2025 Q3	$4.31K	Hold	45	–	–	﹤0.01%	443
2025 Q2	$2.19K	Buy	+45	New	+$1.08K	﹤0.01%	452

Vermillion & White Wealth Management Group's CDTX Position: Q1 2026 in Review

Vermillion & White Wealth Management Group sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 45 shares — an estimated $9.94K sold.

Vermillion & White Wealth Management Group first reported a position in CDTX in Q2 2025 and held it in 3 quarters. The position peaked at $9.94K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Vermillion & White Wealth Management Group reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Vermillion & White Wealth Management Group sold 45 Cidara Therapeutics shares in Q1 2026, an estimated $9.94K.
Vermillion & White Wealth Management Group first reported a position in Cidara Therapeutics in Q2 2025 and held it in 3 quarters.
Vermillion & White Wealth Management Group's Cidara Therapeutics position peaked at $9.94K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Vermillion & White Wealth Management Group's 13F filing for Q1 2026, filed 14 May 2026.